Skip to main content

Table 1 Characteristics of BioMe participants eligible to receive results and receiving results through a pilot genomic screening program

From: Implementing genomic screening in diverse populations

Participant demographics and characteristics Eligible to receive results (N = 692) Received P/LP results Downgraded variants (N = 12)
CDC tier 1 (N = 40) hATTR (N = 34) CDC tier 1 + hATTR (N = 74)
Age, median (range) 60 (18–95) 61 (28–83) 57 (30–80) 58 (28–83) 61 (30–76)
Female sex, N (%) 458 (66.2) 33 (82.5) 28 (82.4) 61 (82.4) 8 (66.7)
Self-reported race/ethnicity, N (%)
 African American/African 156 (22.5) 6 (15.0) 18 (52.9) 24 (32.4) 3 (25.0)
 East/Southeast Asian 26 (3.8) 2 (5.0) 0 2 (2.7) 3 (25.0)
 European 186 (26.9) 20 (50.0) 1 (2.9) 21 (28.4) 5 (41.7)
 Hispanic/Latinx 249 (36.0) 8 (20.0) 15 (44.1) 23 (31.1) 0
 Native American 1 (0.1) 0 0 0 0
 Other 41 (5.9) 3 (7.5) 0 3 (4.1) 1 (8.3)
 South Asian 9 (1.3) 0 0 0 0
 Multiple selected 22 (3.2) 1 (2.5) 0 1 (1.4) 0
 Not available 2 (0.3) 0 0 0 0
Spanish as preferred language, N (%) 0 3 (8.8) 3 (4.1)
Prior knowledge of genomic risk, N (%) 14 (35.0) 1 (2.9) 15 (20.3)
Mode of result disclosure, N (%)    
 In-person   24 (60.0) 26 (76.5) 50 (67.6)  
 Telemedicine   16 (40.0) 8 (23.5) 24 (32.4)